Literature DB >> 25765135

Quality management in European screening laboratories in blood establishments: A view of current approaches and trends.

Paulo Pereira1, James O Westgard2, Pedro Encarnação3, Jerard Seghatchian4, Gracinda de Sousa5.   

Abstract

The screening laboratory has a critical role in the post-transfusion safety. The success of its targets and efficiency depends on the management system used. Even though the European Union directive 2002/98/EC requires a quality management system in blood establishments, its requirements for screening laboratories are generic. Complementary approaches are needed to implement a quality management system focused on screening laboratories. This article briefly discusses the current good manufacturing practices and good laboratory practices, as well as the trends in quality management system standards. ISO 9001 is widely accepted in some European Union blood establishments as the quality management standard, however this is not synonymous of its successful application. The ISO "risk-based thinking" is interrelated with the quality risk-management process of the EuBIS "Standards and criteria for the inspection of blood establishments". ISO 15189 should be the next step on the quality assurance of a screening laboratory, since it is focused on medical laboratory. To standardize the quality management systems in blood establishments' screening laboratories, new national and European claims focused on technical requirements following ISO 15189 is needed.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Keywords:  PDCA; Post-transfusion safety; Quality management; Screening test

Mesh:

Year:  2015        PMID: 25765135     DOI: 10.1016/j.transci.2015.02.014

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  3 in total

1.  Health data protection and confidentiality in EU BTC legislation: ethical and safety standards.

Authors:  Anca Parmena Olimid; Daniel Alin Olimid
Journal:  Rom J Morphol Embryol       Date:  2021 Oct-Dec       Impact factor: 0.833

Review 2.  COVID-19-another influential event impacts on laboratory medicine management.

Authors:  YunTao Luo; JingHua Wang; MinMin Zhang; QingZhong Wang; Rong Chen; XueLiang Wang; HuaLiang Wang
Journal:  J Clin Lab Anal       Date:  2021-05-25       Impact factor: 2.352

3.  Application of PDCA Circulation Regulation Combined with Nursing Mark in Nursing Safety and Quality Regulation of Disinfection Supply Center.

Authors:  Xiuyu Cai; Jun Li; Wen Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-16       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.